Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference [Yahoo! Finance]
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition [Yahoo! Finance]
Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target lowered by analysts at Wedbush from $24.00 to $13.00. They now have an "outperform" rating on the stock.
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target lowered by analysts at HC Wainwright from $17.00 to $14.00. They now have a "buy" rating on the stock.